Phase 2 Chronic Inflammation Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
Recurrent Grade 3b Follicular LymphomaRefractory Grade 3b Follicular LymphomaRecurrent Transformed Non-Hodgkin Lymphoma+28 more
Mayo Clinic41 enrolled7 locationsNCT06834373
Recruiting
Phase 2
The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation
Type 1 DiabetesInsulin SensitivityChronic Inflammation
Asger Lund, MD26 enrolled1 locationNCT07247734
Recruiting
Phase 2
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
Obesity and OverweightHIVChronic Inflammation
University of Hawaii12 enrolled1 locationNCT06935838
Recruiting
Phase 2
To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
Chronic DiseaseChronic Inflammation
HoHo Biotech60 enrolled2 locationsNCT06401785
Completed
Phase 2
Investigating the effect of a soluble seaweed dietary fibre on gut, metabolic and skin health.
Keratoderma/psoriatic skin conditionIncreased Chronic InflammationImpaired Glucose Tolerance and Insulin resistance+2 more
University of Wollongong80 enrolled1 locationACTRN12617001010381